2024-11-20 – Press Releases – www.prnewswire.com
The company will provide manufacturing services through 2031 in deals worth over USD 668 million Samsung Biologics’ cumulative contract value for 2024 surpasses USD 4 billion with latest deals INCHEON, South Korea, Nov. 20, 2024 /PRNewswire/ — Samsung Biologics (KRX: 207940.KS), a global…